CCCC
C4 Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.39
−0.73%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 18.28x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.69x
- Price / sales
- 11.90x
- Price / cash flow
- -4.91x
Enterprise value
- Enterprise value
- $220.3M
- EV / sales
- 6.29x
- EV / EBITDA
- -2.24x
- EV / EBIT
- -1.97x
- Market cap
- $417.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026